Cutler Group’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Cutler Group’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-793	Closed	-$28K	–	7844
2016 Q4	$28K	Buy	+793	New	+$28.1K	﹤0.01%	3138

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Cutler Group's CLCD Position: Q1 2017 in Review

Cutler Group sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 793 shares — an estimated $28K sold.

Cutler Group first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $28K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Cutler Group reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Cutler Group sold 793 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $28K.
Cutler Group first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
Cutler Group's CoLucid Pharmaceuticals, Inc. position peaked at $28K in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Cutler Group's 13F filing for Q1 2017, filed 11 Apr 2017.